Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Lilly discloses new agents for influenza

Jan. 20, 1998

Novel semisynthetic macrolides prepared at Abbott

Jan. 20, 1998

Lilly discloses novel compounds for influenza

Jan. 19, 1998

Merck & Co. claims carbapenems active against methicillin-resistant staphylococci

Jan. 19, 1998

Preclinical evaluation of leishmaniasis Rx reported

Jan. 19, 1998

Artelinic acid: an attractive candidate for development as an antimalarial agent

Jan. 19, 1998

New antimalarial agent submitted to extensive clinical testing

Jan. 19, 1998

U. of Mass. scientists design anti-EBV antisense oligonucleotides

Jan. 16, 1998

Lilly describes new glycopeptides active against VRE

Jan. 15, 1998

Genzyme Transgenics breakthrough could lead to potential malaria vaccine

Jan. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...